Dimeji Lanade

Dimeji Lanade: MSS Tumors in Lynch Syndrome and Better Understanding Response to Immunotherapy

Dimeji Lanade, Hematology/Oncology Fellow at Atrium Health, shared on X:

“MSS tumors in lynch syndrome and better understanding response to immunotherapy

MSI-H vs MSS Tumors in Lynch Syndrome -Are there patient and disease distinctions between the two? Our study suggested so!
Thanks ESMO.”

MORE POSTS FEATURING ESMOGI25.